Heikki Miettinen
Nessuna posizione attualmente
Profilo
Heikki Miettinen formerly worked at Innofinance Oy, as Investment Director & Partner from 2003 to 2016, Northern Antibiotics Oy, as Director, Zora Biosciences Oy, as Director, and Next Biomed Technologies NBT Oy, as Director.
Mr. Miettinen received his graduate degree from Aalto University.
Precedenti posizioni note di Heikki Miettinen
| Società | Posizione | Fine |
|---|---|---|
Innofinance Oy
 Innofinance Oy Investment ManagersFinance Innofinance Oy (Innofinance) is an independent management-owned private equity firm founded in 1997. The firm is headquartered in Espoo, Finland. | Investitore di Private Equity | 31/12/2016 |
Northern Antibiotics Oy
 Northern Antibiotics Oy Pharmaceuticals: MajorHealth Technology Northern Antibiotics Oy engages in the discovery and development of novel antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. The company was founded by Martti Sakari Vaara and Timo Ilmari Vaara in 2003 and is headquartered in Helsinki, Finland. | Direttore/Membro del Consiglio | - |
Next Biomed Technologies NBT Oy
 Next Biomed Technologies NBT Oy Medical SpecialtiesHealth Technology Next Biomed Technologies NBT Oy manufactured diagnostics kits. It developed novel diagnostic solutions based on multifunctional recombinant polypeptides. The company was founded by Paul Partanen in 2006 and was headquartered in Helsinki, Finland. | Direttore/Membro del Consiglio | - |
Zora Biosciences Oy
 Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Direttore/Membro del Consiglio | - |
Formazione di Heikki Miettinen
| Aalto University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
Innofinance Oy
Innofinance Oy Investment ManagersFinance Innofinance Oy (Innofinance) is an independent management-owned private equity firm founded in 1997. The firm is headquartered in Espoo, Finland. | Finance |
Zora Biosciences Oy
Zora Biosciences Oy Medical/Nursing ServicesHealth Services Zora Biosciences Oy develops biomarker-based diagnostics tests. It focuses on cardiovascular disease. The company's main product is coronary event risk test. Zora Biosciences was founded by Reini Juhani Hurme, Reijo Laaksonen, and Matej Orešic on December 14, 2006 and is headquartered in Espoo, Finland. | Health Services |
Next Biomed Technologies NBT Oy
Next Biomed Technologies NBT Oy Medical SpecialtiesHealth Technology Next Biomed Technologies NBT Oy manufactured diagnostics kits. It developed novel diagnostic solutions based on multifunctional recombinant polypeptides. The company was founded by Paul Partanen in 2006 and was headquartered in Helsinki, Finland. | Health Technology |
Northern Antibiotics Oy
Northern Antibiotics Oy Pharmaceuticals: MajorHealth Technology Northern Antibiotics Oy engages in the discovery and development of novel antibiotics against multidrug-resistant gram-negative bacteria. It develops compounds, which are active against difficult-to-treat gram-negative bacteria, such as multi-resistant Escherichia coli, Klebsiella pneumoniae, other species of Enterobacteriaceae, and Acinetobacter baumannii. The company was founded by Martti Sakari Vaara and Timo Ilmari Vaara in 2003 and is headquartered in Helsinki, Finland. | Health Technology |
- Borsa valori
- Insiders
- Heikki Miettinen
